The effect of hyaluronic acid on osteopontin and CD44 mRNA of fibroblast-like synoviocytes in patients with osteoarthritis of the knee

Rheumatology International

Volumn 33, Issue 1, 2013, Pages 79-83

  Zhang, Fang Jie ^a   Gao, Shu Guang ^a,b   Cheng, Ling ^a   Tian, Jian ^a   Xu, Wen Shuo ^a,c   Luo, Wei ^a   Song, Yang ^a   Yang, Yang ^a   Lei, Guang Hua ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c CHENGDE MEDICAL COLLEGE   (China)

Author keywords

CD44; Fibroblast like synoviocytes; Hyaluronic acid; Osteoarthritis; Osteopontin

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; MESSENGER RNA; OSTEOPONTIN; VIMENTIN;

ARTICLE; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FIBROBLAST LIKE SYNOVIOCYTE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KNEE OSTEOARTHRITIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SYNOVIAL FLUID; SYNOVIOCYTE; SYNOVITIS; UPREGULATION;

ACTINS; ADJUVANTS, IMMUNOLOGIC; ANTIGENS, CD44; CELLS, CULTURED; FIBROBLASTS; GENE EXPRESSION; HUMANS; HYALURONIC ACID; OSTEOARTHRITIS, KNEE; OSTEOPONTIN; RNA, MESSENGER; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; UP-REGULATION;

EID: 84872301400     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2339-3     Document Type: Article

References (25)

1. Malemud CJ, Islam N, Haqqi TM (2003) Pathophysiological mechanisms in osteoarthritis lead to novel therapeutic strategies. Cells Tissues Organs 174:34-48
2. Dahl LB, Dahl IM, Engstro m-Laurent A, Granath K (1985) Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 44:817-822
3. Xu G, Nie H, Li N, Zheng W, Zhang D, Feng G (2005) Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. J Clin Invest 115:1060-1067
4. Gao SG, Li KH, Zeng KB, Tu M, Xu M, Lei GH (2010) Elevated osteopontin level of synovial fluid and articular cartilage is associated with disease severity in knee osteoarthritis patients. Osteoarthr Cartil 18:82-87
5. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303-1313
6. Weber GF, Ashkar S, Glimcher MJ, Cantor H (1996) Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271:509-512
7. Dunn S, Kolomytkin OV, Waddell DD, Marino AA (2009) Hyaluronan-binding receptors: possible involvement in osteoarthritis. Mod Rheumatol 19:151-155
8. Stebulis JA, Rossetti RG, Atez FJ, Zurier RB (2005) Fibroblast-like synovial cells derived from synovial fluid. J Rheumatol 32:301-306
9. Matsui Y, Iwasaki N, Kon S, Takahashi D, Morimoto J, Matsui Y, Denhardt DT, Rittling S, Minami A, Uede T (2009) Accelerated development of aging-associated and instability-induced osteoarthritis in osteopontin-deficient mice. Arthr Rheum 60:2362-2371
10. Attur MG, Dave MN, Stuchin S, Kowalski AJ, Steiner G, Abramson SB, Denhardt DT, Amin AR (2001) Osteopontin: an intrinsic inhibitor of inflammation in cartilage. Arthr Rheum 44:578-584
11. Larkin J, Renukaradhya GJ, Sriram V, Du W, Gervay-Hague J, Brutkiewicz RR (2006) CD44 differentially activates mouse NK T cells and conventional T cells. J Immunol 177:268-279
12. Clark RA, Alon R, Springer TA (1972) CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma. J Cell Biol 134:1075-1087
13. de la Motte CA, Hascall VC, Drazba J, Bandyopadhyay SK, Strong SA (2003) Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid: polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function. Am J Pathol 163:121-133
14. Mori H, Tomari T, Koshikawa N, Kajita M, Itoh Y, Sato H, Tojo H, Yana I, Seiki M (2002) CD44 directs membrane-type 1 matrix metalloproteinase to lemellipodia by associating with its hemopexin-like domain. EMBO J 21:3949-3959
15. Mikecz K, Dennis K, Shi M, Kim JH (1999) Modulation of hyaluronan receptor (CD44) function in vivo in a murine model of rheumatoid arthritis. Arthr Rheum 42:659-668
16. Neidhart M, Gay RE, Gay S (2000) Anti-interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts. Arthr Rheum 43:1719-1728
17. Weigel JA, Raymond RC, McGary C, Singh A, Weigel PH (2003) A blocking antibody to the hyaluronan receptor for endocytosis (HARE) inhibits hyaluronan clearance by perfused liver. J Biol Chem 14:9808-9812
18. Stern R, Kogan G, Jedrzejas MJ, Soltés L (2007) The many ways to cleave hyaluronan. Biotechnol Adv 25:537-557
19. Kim MS, Park MJ, Moon EJ, Kim SJ, Lee CH, Yoo H, Shin SH, Song ES, Lee SH (2005) Hyaluronic acid induces osteopontin via the phosphatidylinositol 3-kinase/Akt pathway to enhance the motility of human glioma cells. Cancer Res 65:686-691
20. Martínez-Sanz E, Ossipov DA, Hilborn J, Larsson S, Jonsson KB, Varghese OP (2011) Bone reservoir: injectable hyaluronic acid hydrogel for minimal invasive bone augmentation. J Control Release 152:232-240
21. Xu C, Wang Y, Yu X, Chen X, Li X, Yang X, Li S, Zhang X, Xiang AP (2009) Evaluation of human mesenchymal stem cells response to biomimetic bioglass-collagen-hyaluronic acid-phosphatidylserine composite scaffolds for bone tissue engineering. J Biomed Mater Res A 88:264-273
22. Mendes RM, Silva GA, Lima MF, Calliari MV, Almeida AP, Alves JB, Ferreira AJ (2008) Sodium hyaluronate accelerates the healing process in tooth sockets of rats. Arch Oral Biol 53:1155-1162
23. Kim J, Kim IS, Cho TH, Kim HC, Yoon SJ, Choi J, Park Y, Sun K, Hwang SJ (2010) In vivo evaluation of MMP sensitive high-molecular weight HA-based hydrogels for bone tissue engineering. J Biomed Mater Res A 95:673-681
24. Gao C, Guo H, Downey L, Marroquin C, Wei J, Kuo PC (2003) Osteopontin-dependent CD44v6 expression and cell adhesion in HepG2. Carcinogenesis 24:1871-1878
25. Cook AC, Chambers AF, Turley EA, Tuck AB (2006) Osteopontin induction of hyaluronan synthase 2 expression promotes breast cancer malignancy. J Biol Chem 281:24381-24389